CA2549971A1 - Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke - Google Patents
Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke Download PDFInfo
- Publication number
- CA2549971A1 CA2549971A1 CA002549971A CA2549971A CA2549971A1 CA 2549971 A1 CA2549971 A1 CA 2549971A1 CA 002549971 A CA002549971 A CA 002549971A CA 2549971 A CA2549971 A CA 2549971A CA 2549971 A1 CA2549971 A1 CA 2549971A1
- Authority
- CA
- Canada
- Prior art keywords
- polymorphism
- stroke
- gene
- risk
- polymorphisms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51631303P | 2003-11-03 | 2003-11-03 | |
US60/516,313 | 2003-11-03 | ||
US56779304P | 2004-05-05 | 2004-05-05 | |
US60/567,793 | 2004-05-05 | ||
US62066604P | 2004-10-22 | 2004-10-22 | |
US60/620,666 | 2004-10-22 | ||
PCT/US2004/036495 WO2005041896A2 (en) | 2003-11-03 | 2004-11-03 | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2549971A1 true CA2549971A1 (en) | 2005-05-12 |
Family
ID=34557381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002549971A Abandoned CA2549971A1 (en) | 2003-11-03 | 2004-11-03 | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
Country Status (4)
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005041896A2 (en) | 2003-11-03 | 2005-05-12 | Duke University | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
US20060154276A1 (en) | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
EP1913155A4 (en) * | 2005-06-23 | 2009-08-12 | Univ British Columbia | COAGULATION FACTOR III POLYMORPHISMS ASSOCIATED WITH PREDICTION RELATING TO THE RESULTS AND RESPONSE OF A SUBJECT TO THERAPY |
US20100217121A1 (en) * | 2007-09-27 | 2010-08-26 | Nemoto Kyorindo Co., Ltd. | Liquid injector, fluoroscopic imaging system, and computer program |
WO2010056682A2 (en) | 2008-11-11 | 2010-05-20 | Prometheus Laboratories Inc. | Methods for prediction of inflammatory bowel disease (ibd) using serologic markers |
NZ595471A (en) | 2009-04-14 | 2014-01-31 | Nestec Sa | Inflammatory bowel disease prognostics |
AU2010266028B2 (en) | 2009-06-25 | 2015-04-30 | Société des Produits Nestlé S.A. | Methods for diagnosing irritable bowel syndrome |
WO2011060098A1 (en) | 2009-11-10 | 2011-05-19 | Prometheus Laboratories Inc. | Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis |
BR112013009376A2 (pt) | 2010-10-18 | 2016-07-26 | Nestec Sa | métodos para determinar isótipos de anticorpos antifármacos |
BR112013020981A2 (pt) | 2011-02-17 | 2016-10-11 | Nestec Sa | ensaios para a detecção de auto-anticorpos para os fármacos anti-tnf<244> |
SG194710A1 (en) | 2011-05-10 | 2013-12-30 | Nestec Sa | Methods of disease activity profiling for personalized therapy management |
AU2012325798B2 (en) | 2011-10-21 | 2015-11-26 | Société des Produits Nestlé S.A. | Methods for improving inflammatory bowel disease diagnosis |
WO2014054013A1 (en) | 2012-10-05 | 2014-04-10 | Nestec S.A. | Methods for predicting and monitoring mucosal healing |
CN103224981A (zh) * | 2013-01-24 | 2013-07-31 | 武汉康圣达医学检验所有限公司 | 一种质谱法检测非小细胞型肺癌放疗毒副作用相关多态性位点基因型的引物组及方法 |
WO2014145705A2 (en) | 2013-03-15 | 2014-09-18 | Battelle Memorial Institute | Progression analytics system |
BR112015029320A8 (pt) | 2013-05-24 | 2023-01-03 | Nestec Sa | Ensaios específicos de vias para predição de diagnóstico de síndrome do intestino irritável |
EP3077818B1 (en) | 2013-12-03 | 2020-02-05 | Prometheus Biosciences, Inc. | Methods for predicting post-operative recurrence of crohn's disease |
WO2015166461A1 (en) | 2014-05-01 | 2015-11-05 | Nestec S.A. | Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels |
WO2016088068A1 (en) | 2014-12-02 | 2016-06-09 | Nestec S.A. | Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease |
WO2019073391A1 (en) | 2017-10-10 | 2019-04-18 | Nestec S.A. | METHODS OF MONITORING VEDOLIZUMAB TREATMENT |
RU2745360C1 (ru) * | 2020-07-20 | 2021-03-24 | Государственное бюджетное учреждение здравоохранения "Научно-исследовательский институт - краевая клиническая больница N1 имени профессора С.В. Очаповского" Министерства здравоохранения Краснодарского края (ГБУЗ "НИИ-ККБ N1" МЗ КК) | Способ прогнозирования послеоперационных осложнений при торакальных операциях |
CN112226494A (zh) * | 2020-10-21 | 2021-01-15 | 上海鼎晶生物医药科技股份有限公司 | 一种AGTR1基因rs5186位点多态性检测用引物组及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1191908A (en) | 1915-03-24 | 1916-07-18 | Frank Petrak | Traction-wheel of the portable-track type. |
US6686338B1 (en) | 1996-02-23 | 2004-02-03 | The Board Of Regents Of The University Of Nebraska | Enzyme inhibitors for metabolic redirection |
US6693052B2 (en) | 1996-10-15 | 2004-02-17 | Warwick Mills, Inc. | Garment including protective fabric |
GB9915939D0 (en) | 1999-07-08 | 1999-09-08 | Johnson Matthey Plc | Improvements in pollution control |
US6775783B1 (en) | 1999-08-13 | 2004-08-10 | Cisco Technology, Inc. | Client security for networked applications |
US6781754B2 (en) | 2000-06-07 | 2004-08-24 | Cirvine Corporation | Interleaver using spatial birefringent elements |
EP1816214B1 (en) | 2000-07-11 | 2008-06-25 | Kirk Hogan | Methods and compositions for perioperative genomic profiling |
WO2002038586A2 (en) | 2000-11-09 | 2002-05-16 | Genaissance Pharmaceuticals, Inc. | Haplotypes of the il6 gene |
US6635181B2 (en) | 2001-03-13 | 2003-10-21 | The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations | Continuous, hybrid field-gradient device for magnetic colloid based separations |
JP2003057537A (ja) | 2001-08-21 | 2003-02-26 | Pentax Corp | 像ブレ補正系を備えた観察用光学系 |
CA2518957A1 (en) | 2003-03-10 | 2004-09-23 | Applera Corporation | Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
WO2005041896A2 (en) | 2003-11-03 | 2005-05-12 | Duke University | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
US7592141B2 (en) | 2004-12-13 | 2009-09-22 | Duke University | Methods of identifying individuals at reduced risk of sepsis |
WO2006116197A2 (en) | 2005-04-22 | 2006-11-02 | Duke University | Methods of identifying individuals at risk of perioperative myocardial injury, major adverse cardiac events, cognitive decline, arrhythmias, depression or bleeding |
-
2004
- 2004-11-03 WO PCT/US2004/036495 patent/WO2005041896A2/en active Application Filing
- 2004-11-03 EP EP04800614A patent/EP1687447A4/en not_active Withdrawn
- 2004-11-03 CA CA002549971A patent/CA2549971A1/en not_active Abandoned
- 2004-11-03 US US10/979,816 patent/US7439019B2/en not_active Expired - Fee Related
-
2008
- 2008-02-29 US US12/073,113 patent/US8187807B2/en active Active
-
2012
- 2012-04-24 US US13/454,929 patent/US20120322667A1/en not_active Abandoned
-
2013
- 2013-12-06 US US14/099,718 patent/US9556486B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US8187807B2 (en) | 2012-05-29 |
WO2005041896A2 (en) | 2005-05-12 |
US20090075271A1 (en) | 2009-03-19 |
EP1687447A4 (en) | 2008-04-02 |
US7439019B2 (en) | 2008-10-21 |
US9556486B2 (en) | 2017-01-31 |
WO2005041896A3 (en) | 2006-02-02 |
US20060024682A1 (en) | 2006-02-02 |
US20120322667A1 (en) | 2012-12-20 |
EP1687447A2 (en) | 2006-08-09 |
US20140141429A1 (en) | 2014-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9556486B2 (en) | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke | |
Tzur et al. | APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease | |
Stafford-Smith et al. | Association of genetic polymorphisms with risk of renal injury after coronary bypass graft surgery | |
Mathew et al. | Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery | |
Peyvandi et al. | Genetic sequence analysis of inherited bleeding diseases | |
Kathiresan et al. | Common genetic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk | |
Zhang et al. | Genetic associations with expression for genes implicated in GWAS studies for atherosclerotic cardiovascular disease and blood phenotypes | |
Welsby et al. | Genetic factors contribute to bleeding after cardiac surgery | |
Zhang et al. | Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population | |
Jimenez Rivera et al. | Factors associated with excessive bleeding in cardiopulmonary bypass patients: a nested case-control study | |
Pizzolo et al. | Basophil blood cell count is associated with enhanced factor II plasma coagulant activity and increased risk of mortality in patients with stable coronary artery disease: not only neutrophils as prognostic marker in ischemic heart disease | |
Appelboom et al. | Complement Factor H Y402H polymorphism is associated with an increased risk of mortality after intracerebral hemorrhage | |
Hemeed et al. | Relationship of angiotensin converting enzyme (I/D) polymorphism (rs4646994) and coronary heart disease among a male Iraqi population with type 2 diabetes mellitus | |
Krischek et al. | Association of the Jun dimerization protein 2 gene with intracranial aneurysms in Japanese and Korean cohorts as compared to a Dutch cohort | |
AlBacha et al. | High incidence of ACE/PAI-1 in association to a spectrum of other polymorphic cardiovascular genes involving PBMCs proinflammatory cytokines in hypertensive hypercholesterolemic patients: reversibility with a combination of ACE inhibitor and statin | |
Fujimaki et al. | Association of genetic variants of the α‑kinase 1 gene with myocardial infarction in community‑dwelling individuals | |
Wilker et al. | Postural changes in blood pressure associated with interactions between candidate genes for chronic respiratory diseases and exposure to particulate matter | |
Alaa et al. | Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients | |
Welsby et al. | Association of the 98T ELAM-1 polymorphism with increased bleeding after cardiac surgery | |
Iribarren et al. | Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene | |
Ben-Hadj-Khalifa et al. | Functional interleukin-10 promoter variants in coronary artery disease patients in Tunisia | |
Dhawan et al. | Is endothelin gene polymorphism associated with postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting? | |
Enjeti et al. | Genomic investigation of inherited thrombotic microangiopathy—aHUS and TTP | |
Yang et al. | MMP-2 gene polymorphisms in type 2 diabetes mellitus diabetic retinopathy | |
Abdul et al. | Plasma levels of plasminogen activator inhibitor‐1 and bleeding phenotype in patients with von Willebrand disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |